Search

everythinglearnresearchcommunity

for

Search:↓

Androstenedione is better than testosterone for diagnosing PCOS in Indian women.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.

A young girl with high testosterone was thought to have a tumor but actually had PCOS, which was treated with birth control pills.

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.

Vitamin D may improve fertility in women with PCOS.

MicroRNAs could be key biomarkers and therapeutic targets for PCOS.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

Most women with Polycystic Ovary Syndrome (PCOS) have skin issues like excessive hair, acne, or hair loss. Hormone imbalances are common, and age, certain hormones, and hormone ratios can predict acne. Obesity, infertility, and high cholesterol are also common in these women.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Both contraceptive pill doses effectively reduced androgen levels in women with PCOS.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Ovarian wedge resection helped regulate menstrual cycles but didn't significantly change hormone levels or hair growth in polycystic ovary syndrome.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

Creating specific biological indicators is important for early detection and treatment of PCOS.

The study concluded that personalized treatment, including medical and cosmetic approaches, is effective for women with PCOS and hirsutism.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Removing one ovary helped treat a woman's severe PCOS symptoms when medicine didn't work.

H19 may help cause PCOS by affecting CTGF levels, suggesting a new treatment target.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

Estradiol stops hair growth in mice, but an antagonist can reverse this effect.

Hair loss in postmenopausal women due to ovarian hyperthecosis is rare, but removing the ovaries can significantly improve the condition.

The document concludes that more research is needed to include new treatments in guidelines for Polycystic Ovary Syndrome (PCOS).

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Human hair follicle stem cells improve ovarian function in mice with damaged ovaries.

Hormonal male contraception is effective and could be market-ready, but more research is needed to ensure safety for all ethnic groups.

Human hair follicles can produce stress hormones like the body's main stress response system.